Health Care

U.S. health officials plan to crack down on a growing number of unproven alternative remedies, focusing on those containing dangerous ingredients that have occasionally been linked to serious injury and death.

A Pennsylvania judge overturned a $28 million jury award to a couple who accused Bayer and J&J of failing to warn about risks connected to their drug Xarelto.

If Amazon enters the pharmaceutical business it has the capacity to revolutionize the entire system as we know it, experts suggest.

Toyota is recalling 601,000 more vehicles in the U.S. to replace defective and potentially deadly Takata air bag inflators.

President Donald Trump's pick for health secretary is telling senators he's wary of a broad government role in negotiating prescription drug prices.

Alzheimer’s is going to cripple the U.S., if a disease modifying agent isn’t soon discovered, Merck’s (NYSE:MRK) CEO Ken Frazier told FOX Business’ Maria Bartiromo on ‘Mornings with Maria.”

Mylan CEO Heather Bresch tells FOX Business the company took care of the EpiPen problem and is focusing on new drugs in its pipeline.

Danish drugmaker Novo Nordisk has revised up its offer for Belgian biotech company Ablynx as it looks to find growth opportunities beyond its core business.

An $11 billion burst of biotech bids in just four days has fueled expectations of a 2018 surge in life science deals as large drugmakers shop for promising assets from smaller rivals.

American families are putting off health care treatments until their tax refund is delivered to their bank accounts, according to a new study.

Denmark's Novo Nordisk, the world's biggest maker of insulin, went public with a 2.6 billion euro ($3.1 billion) bid for Belgian biotech group Ablynx on Monday as it seeks to bolster its treatments for rare blood disorders.

U.S. biotech pharmaceutical firm Celgene Corp said on Sunday that it had agreed to acquire Impact Biomedicines for as much as $7 billion, subject to certain milestones associated with regulatory hurdles and sales performance.

Pfizer is abandoning research to find new drugs aimed at treating Alzheimer's and Parkinson's disease, the U.S. pharmaceutical company announced on Saturday.

Japanese air bag maker Takata is recalling another 3.3 million faulty air bag inflators as it continues to expand the largest automotive recall in U.S. history.

The state's Agency for Health Care Administration said in a Friday evening news release that one of its employees "was the victim of a malicious phishing email" on Nov. 15.

Stocks that moved substantially or traded heavily Friday: Constellation Brands Inc., down $5.91 to $219.88